Literature DB >> 25589223

Danon disease: a phenotypic expression of LAMP-2 deficiency.

Yukari Endo1, Akiko Furuta, Ichizo Nishino.   

Abstract

Danon disease is an X-linked disorder clinically characterized by the triad of hypertrophic cardiomyopathy, myopathy, and intellectual disability. Cardiomyopathy is a severe and life-threatening problem, for which cardiac transplantation is the only therapeutic option. The most striking finding in muscle biopsy samples is small basophilic granules scattered in myofibers, which are in fact small autophagic vacuoles surrounded by membranes with sarcolemmal features characterized by the recruitment of sarcolemmal proteins and acetylcholine esterase and by the presence of basal lamina on its luminal side. The mechanism underlying the formation of these autophagic vacuoles with unique sarcolemmal features (AVSF) still remains a mystery and its origin is unknown. In heart, cardiomyocytes show dramatically increased vacuolation and degenerative features, including myofibrillar disruption and lipofuscin accumulation. In brain, pale granular neurons and neurons with lipofuscin-like granules may be seen. Danon disease is caused by loss-of-function mutations in the LAMP2 gene, which encodes lysosome-associated membrane protein 2 (LAMP-2), a single-spanned transmembrane protein localized in the limiting membranes of lysosomes and late endosomes. Most mutations lead to splicing defects or protein truncation, resulting in a loss of transmembrane and/or cytoplasmic domains, leading to LAMP-2 protein deficiency. LAMP-2 is required for the maturation of autophagosomes by fusion with lysosomes; therefore, LAMP-2 deficiency leads to a failure in macroautophagy. There are three LAMP-2 isoforms, LAMP-2A, -2B, and -2C. Clinical features of Danon disease are thought to be mediated by loss of the LAMP-2B isoform which is the major isoform expressed in muscle. It is also known that LAMP-2 plays a role in chaperone-mediated autophagy and RNA- and DNA-targeting autophagy. However, the precise pathophysiological mechanism through which LAMP-2 deficiency causes Danon disease is still not fully understood and its elucidation would promote the development of new therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25589223     DOI: 10.1007/s00401-015-1385-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  36 in total

Review 1.  Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.

Authors:  Toru Kubo; Hiroaki Kitaoka
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

2.  Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy.

Authors:  Alexey V Dvornikov; Mingmin Wang; Jingchun Yang; Ping Zhu; Tai Le; Xueying Lin; Hung Cao; Xiaolei Xu
Journal:  J Mol Cell Cardiol       Date:  2019-06-20       Impact factor: 5.000

Review 3.  Danon disease - dysregulation of autophagy in a multisystem disorder with cardiomyopathy.

Authors:  Teisha J Rowland; Mary E Sweet; Luisa Mestroni; Matthew R G Taylor
Journal:  J Cell Sci       Date:  2016-05-10       Impact factor: 5.285

Review 4.  Dysfunction of chaperone-mediated autophagy in human diseases.

Authors:  Zhaozhong Liao; Bin Wang; Wenjing Liu; Qian Xu; Lin Hou; Jinlian Song; Qingming Guo; Ning Li
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

5.  The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain.

Authors:  Abdul-Raouf Issa; Jun Sun; Céline Petitgas; Ana Mesquita; Amina Dulac; Marion Robin; Bertrand Mollereau; Andreas Jenny; Baya Chérif-Zahar; Serge Birman
Journal:  Autophagy       Date:  2018-08-10       Impact factor: 16.016

Review 6.  Biochemical and clinical aspects of glycogen storage diseases.

Authors:  Sara S Ellingwood; Alan Cheng
Journal:  J Endocrinol       Date:  2018-06-06       Impact factor: 4.286

Review 7.  Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders.

Authors:  Bradley C Nelson; Sherin I Hashem; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

8.  A Critical Evaluation of Liver Pathology in Humans with Danon Disease and Experimental Correlates in a Rat Model of LAMP-2 Deficiency.

Authors:  Lu Wang; Jingbo Wang; Weile Cai; Yongquan Shi; Xinmin Zhou; Guanya Guo; Changcun Guo; Xiaofeng Huang; Zheyi Han; Shuai Zhang; Shuoyi Ma; Xia Zhou; Daiming Fan; M Eric Gershwin; Ying Han
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

9.  Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.

Authors:  Daniel C Cole; Youngcheul Chung; Khatuna Gagnidze; Kaitlyn H Hajdarovic; Violeta Rayon-Estrada; Dewi Harjanto; Benedetta Bigio; Judit Gal-Toth; Teresa A Milner; Bruce S McEwen; F Nina Papavasiliou; Karen Bulloch
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-22       Impact factor: 11.205

10.  Lysosome-associated membrane protein-2 deficiency increases the risk of reactive oxygen species-induced ferroptosis in retinal pigment epithelial cells.

Authors:  Jong-Jer Lee; Kenji Ishihara; Shoji Notomi; Nikolaos E Efstathiou; Takashi Ueta; Daniel Maidana; Xiaohong Chen; Yasuhiro Iesato; Alberto Caligiana; Demetrios G Vavvas
Journal:  Biochem Biophys Res Commun       Date:  2019-10-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.